Successful treatment of multidrug resistant Acinetobacter baumannii meningitis

被引：7
|
作者：
Sacar, Suzan [1 ]
Turgut, H. [1 ]
Cenger, D. Hircin [1 ]
Coskun, E. [2 ]
Asan, A. [1 ]
Kaleli, I. [3 ]
机构：
[1] Pamukkale Univ Hosp, Infect Dis & Clin Microbiol Dept, Denizli, Turkey
[2] Pamukkale Univ Hosp, Dept Neurosurg, Denizli, Turkey
[3] Pamukkale Univ Hosp, Microbiol & Clin Microbiol Dept, Denizli, Turkey
来源：
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2007年 / 1卷 / 03期
关键词：
Acinetobacter baumannii; Post-surgical meningitis; High dose meropenem;
D O I：
10.3855/jidc.376
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Background: Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly. Cases: We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy. Conclusions: Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.
引用
收藏
页码：342 / 344
页数：3
相关论文
共 50 条
  • [41] Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
    Li, Jian
    Rayner, Craig R.
    Nation, Roger L.
    Owen, Roxanne J.
    Spelman, Denis
    Tan, Kar Eng
    Liojios, Lisa
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 2946 - 2950
  • [42] Confronting multidrug-resistant Acinetobacter baumannii: a review
    Neonakis, Ioannis K.
    Spandidos, Demetrios A.
    Petinaki, Efthimia
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (02) : 102 - 109
  • [43] Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii
    AlAmri, Aisha M.
    AlQurayan, Ameerah M.
    Sebastian, Tunny
    AlNimr, Amani
    [J]. CURRENT MICROBIOLOGY, 2020, 77 (03) : 335 - 342
  • [44] Chitosan as an effective inhibitor of multidrug resistant Acinetobacter baumannii
    Costa, E. M.
    Silva, S.
    Vicente, S.
    Veiga, M.
    Tavaria, F.
    Pintado, M. M.
    [J]. CARBOHYDRATE POLYMERS, 2017, 178 : 347 - 351
  • [45] Multidrug-resistant Acinetobacter baumannii: A therapeutic challenge
    Martinez Perez, Maria
    Vazquez Blanquino, Alberto
    Moron, Rocio
    Perez Rodriguez, Lucia
    Chueca Porcuna, Natalia
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2023, 36 (05) : 536 - 538
  • [46] Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii
    Al-Shaer, Mohammad
    Nazer, Lama H.
    Kherallah, Mazen
    [J]. ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) : 766 - 771
  • [47] Durlobactam in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections: A Systematic Review
    Granata, Guido
    Taglietti, Fabrizio
    Schiavone, Francesco
    Petrosillo, Nicola
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [48] Novel therapies for treatment of multidrug-resistant Acinetobacter baumannii skin infections
    Mihu, Mircea Radu
    Martinez, Luis R.
    [J]. VIRULENCE, 2011, 2 (02) : 97 - 102
  • [49] Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
    Shin, Jung Ar
    Chang, Yoon Soo
    Kim, Hyung Jung
    Kim, Se Kyu
    Chang, Joon
    Ahn, Chul Min
    Byun, Min Kwang
    [J]. YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 974 - 984
  • [50] Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
    Kumar, Sunil
    Anwer, Razique
    Azzi, Arezki
    [J]. MICROORGANISMS, 2021, 9 (10)
12345